Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes

OBJECTIVE This study evaluated closed-loop insulin delivery with a model predictive control (MPC) algorithm during early (12–16 weeks) and late gestation (28–32 weeks) in pregnant women with type 1 diabetes. RESEARCH DESIGN AND METHODS Ten women with type 1 diabetes (age 31 years, diabetes duration 19 years, BMI 24.1 kg/m2, booking A1C 6.9%) were studied over 24 h during early (14.8 weeks) and late pregnancy (28.0 weeks). A nurse adjusted the basal insulin infusion rate from continuous glucose measurements (CGM), fed into the MPC algorithm every 15 min. Mean glucose and time spent in target (63–140 mg/dL), hyperglycemic (>140 to ≥180 mg/dL), and hypoglycemic (<63 to ≤50 mg/dL) were calculated using plasma and sensor glucose measurements. Linear mixed-effects models were used to compare glucose control during early and late gestation. RESULTS During closed-loop insulin delivery, median (interquartile range) plasma glucose levels were 117 (100.8–154.8) mg/dL in early and 126 (109.8–140.4) mg/dL in late gestation (P = 0.72). The overnight mean (interquartile range) plasma glucose time in target was 84% (50–100%) in early and 100% (94–100%) in late pregnancy (P = 0.09). Overnight mean (interquartile range) time spent hyperglycemic (>140 mg/dL) was 7% (0–40%) in early and 0% (0–6%) in late pregnancy (P = 0.25) and hypoglycemic (<63 mg/dL) was 0% (0–3%) and 0% (0–0%), respectively (P = 0.18). Postprandial glucose control, glucose variability, insulin infusion rates, and CGM sensor accuracy were no different in early or late pregnancy. CONCLUSIONS MPC algorithm performance was maintained throughout pregnancy, suggesting that overnight closed-loop insulin delivery could be used safely during pregnancy. More work is needed to achieve optimal postprandial glucose control.

[1]  W. Clarke The original Clarke Error Grid Analysis (EGA). , 2005, Diabetes technology & therapeutics.

[2]  Janet M. Allen,et al.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2010, The Lancet.

[3]  S. Kalhan,et al.  Glucose turnover and gluconeogenesis in human pregnancy. , 1997, The Journal of clinical investigation.

[4]  George Dailey,et al.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.

[5]  J. Pickup,et al.  NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidance , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[6]  D. Dunger,et al.  Overnight closed-loop glucose control following consumption of alcohol in adults with type 1 diabetes , 2010 .

[7]  T. Skinner,et al.  Effectiveness of a Regional Prepregnancy Care Program in Women With Type 1 and Type 2 Diabetes , 2010, Diabetes Care.

[8]  A. Trujillo,et al.  Insulin Analogs and Pregnancy , 2007 .

[9]  E. Torlone,et al.  Insulin analogs and pregnancy: an update , 2009, Acta Diabetologica.

[10]  Howard Wolpert,et al.  Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group , 2008 .

[11]  H. Murphy,et al.  Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial , 2008, BMJ : British Medical Journal.

[12]  A. Lapolla,et al.  Insulin analogs in pregnancy , 2005 .

[13]  G. Visser,et al.  Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands , 2004, BMJ : British Medical Journal.

[14]  Boris Kovatchev,et al.  Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy , 2007, Journal of diabetes science and technology.

[15]  R. Hovorka Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[16]  U. Hanson,et al.  Obstetric and Perinatal Outcomes in Type 1 Diabetic Pregnancies , 2009, Diabetes Care.

[17]  A. Tripathi,et al.  Preconception Counseling in Women With Diabetes , 2009, Diabetes Care.

[18]  M. Hod,et al.  Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. , 2007, American journal of obstetrics and gynecology.

[19]  Howard C. Zisser,et al.  Continuous glucose monitoring during pregnancy. , 2009, Diabetes technology & therapeutics.

[20]  T. Farrell,et al.  Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. , 2007, American journal of obstetrics and gynecology.

[21]  P. Catalano,et al.  Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction , 2010, Diabetologia.

[22]  F. Ovalle,et al.  Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes , 2009 .

[23]  D. Acolet,et al.  Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study , 2006, BMJ : British Medical Journal.